Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",24020,85,1.15 [0.87-1.51],0.3186522456881245
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24524,128,1.06 [0.85-1.33],0.5891567188751665
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24310,892,1.07 [0.98-1.17],0.1096567517650756
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Candidiasis,24549,266,1.00 [0.85-1.17],0.9905435346829174
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23852,2423,1.06 [1.01-1.12],0.0207167853524528
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),24079,1844,1.03 [0.97-1.10],0.2869497398234177
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24370,871,1.06 [0.97-1.15],0.2181656321120371
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24481,38,0.88 [0.58-1.35],0.5731672231889012
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23423,566,1.09 [0.98-1.22],0.1047631899603079
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22626,535,1.10 [0.99-1.23],0.0826684005677337
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22853,151,1.06 [0.86-1.30],0.5854463689063798
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18246,1070,1.11 [1.03-1.20],0.0096551714753897
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22655,252,1.13 [0.97-1.33],0.1250782981334987
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24514,1015,1.05 [0.97-1.14],0.246390673784798
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Mycoses,24607,324,1.00 [0.86-1.15],0.961205110557328
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23966,548,1.10 [0.99-1.23],0.0778171953850341
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24556,621,1.11 [1.00-1.23],0.0448638256198756
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23629,130,1.04 [0.83-1.30],0.7505184486016079
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24649,29,1.25 [0.78-1.98],0.3511247221978788
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24483,548,1.08 [0.97-1.21],0.1509877888808287
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24507,64,1.14 [0.83-1.56],0.4179969666394375
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24559,154,1.26 [1.03-1.55],0.0236949917516243
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24544,139,1.25 [1.01-1.55],0.0416126992260822
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23721,303,1.16 [1.00-1.34],0.0461668204138337
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23625,207,1.02 [0.85-1.22],0.8222157108900612
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23565,66,1.15 [0.84-1.56],0.3944059783757271
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24622,46,1.24 [0.86-1.78],0.2532182713784089
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24593,115,0.84 [0.66-1.08],0.1749295316807578
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Viral warts,24517,39,0.72 [0.46-1.10],0.127562158576952
VASP,Vasodilator-stimulated phosphoprotein,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24522,44,1.04 [0.70-1.54],0.848149675180843
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm,24384,281,1.21 [1.04-1.40],0.0145339838509533
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24571,67,1.31 [0.96-1.77],0.0840929686672738
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24543,68,1.35 [1.00-1.83],0.0496037546283385
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10999,37,1.18 [0.78-1.79],0.4361407656608631
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",24467,1037,0.96 [0.89-1.04],0.3213667637992536
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of meninges,24637,44,1.24 [0.84-1.81],0.2767800675499238
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24616,48,0.93 [0.64-1.35],0.6913624918849293
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24627,80,1.24 [0.94-1.64],0.127822477240795
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm of ovary,13591,85,1.14 [0.86-1.51],0.3537191534117312
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24641,245,0.87 [0.73-1.02],0.090619192680809
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Caecum,24637,186,1.01 [0.84-1.22],0.9260597715962248
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24583,50,0.94 [0.65-1.36],0.7482619583583341
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Descending colon,24643,159,0.85 [0.69-1.04],0.1220381912574346
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Rectum,24610,255,0.93 [0.79-1.09],0.380431190358211
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24577,485,0.93 [0.83-1.05],0.2243973379724876
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24641,271,0.96 [0.82-1.12],0.5780791283615416
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Carcinoma in situ of breast,11650,75,0.75 [0.55-1.03],0.0754144704795517
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11690,85,0.90 [0.67-1.20],0.4717428546142129
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21249,31,0.91 [0.57-1.45],0.6916953517360029
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",21253,35,1.08 [0.70-1.67],0.7395741732602792
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24610,97,0.95 [0.73-1.24],0.6961835219281666
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Haemangioma, any site",24610,95,0.95 [0.73-1.24],0.7137911186720365
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Leiomyoma of uterus,13019,364,0.94 [0.82-1.08],0.3674433162836855
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Lung cancer and mesothelioma,18266,160,1.13 [0.92-1.39],0.2378718379496149
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Lymphoid leukaemia,21246,28,0.91 [0.55-1.50],0.7207224461893293
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21349,131,1.03 [0.82-1.30],0.7773836345030443
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",21298,80,1.18 [0.89-1.57],0.2551855436094986
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11739,71,0.95 [0.70-1.30],0.7654913887070285
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21264,46,0.70 [0.47-1.04],0.078235455448846
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21273,55,1.04 [0.73-1.47],0.8355661235902242
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",21282,64,1.10 [0.80-1.50],0.5676175846072975
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11717,49,1.45 [1.01-2.08],0.0426669520444108
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",21273,55,1.16 [0.82-1.63],0.4018980030914371
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9907,357,1.06 [0.93-1.21],0.3951124465103951
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",21304,86,1.14 [0.86-1.50],0.3578033685671303
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",21267,49,1.24 [0.87-1.77],0.2427522144543248
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,21274,56,0.87 [0.61-1.24],0.4425872397464595
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanocytic naevi,24438,194,1.06 [0.88-1.28],0.5301911068128397
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanocytic naevi of trunk,24606,88,1.03 [0.79-1.36],0.8070187939271024
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Melanoma in situ,21229,41,1.58 [1.07-2.32],0.0207852707419436
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21274,56,1.14 [0.81-1.60],0.466854415369024
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21324,106,1.11 [0.87-1.42],0.4053068160216625
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21325,107,1.11 [0.86-1.43],0.4240430768081971
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21278,60,1.17 [0.84-1.63],0.3476012472839057
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,Other benign neoplasms of skin,24487,133,1.10 [0.88-1.38],0.3939429642141104
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21788,570,0.98 [0.88-1.09],0.7199121815747633
VASP,Vasodilator-stimulated phosphoprotein,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21818,600,0.98 [0.88-1.10],0.7704697152258801
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24394,266,1.05 [0.90-1.24],0.5142702352093724
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,23382,43,1.03 [0.70-1.53],0.8685535706476403
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,24196,68,1.10 [0.81-1.50],0.5320415677401116
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23929,1986,1.05 [0.99-1.12],0.0773439254612637
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23606,20,0.87 [0.48-1.55],0.6295312915962497
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24330,29,1.25 [0.78-1.98],0.3542905493271875
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24249,910,1.07 [0.98-1.17],0.111661473309582
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24249,910,1.07 [0.98-1.17],0.111661473309582
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,23388,49,1.09 [0.75-1.57],0.6555725643247563
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24400,814,1.07 [0.98-1.17],0.1177933910607197
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,24398,97,1.00 [0.77-1.30],0.9905628490965084
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,24176,48,0.89 [0.61-1.30],0.5461725854703361
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,24167,39,1.29 [0.86-1.93],0.2133000336127517
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24475,174,0.84 [0.69-1.03],0.0891266206318587
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24578,60,1.39 [1.01-1.92],0.0406190623061086
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24451,150,0.76 [0.61-0.94],0.013462867193868
VASP,Vasodilator-stimulated phosphoprotein,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23648,62,1.00 [0.72-1.40],0.9768195286799098
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21143,183,1.00 [0.83-1.21],0.9861830863007228
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22918,110,1.19 [0.94-1.50],0.1552394229036901
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22937,129,1.12 [0.90-1.40],0.313195285303816
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20992,32,1.73 [1.13-2.66],0.0117346415031902
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22869,63,0.92 [0.66-1.28],0.6152121489553689
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22558,125,0.93 [0.74-1.17],0.5424013585696539
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",24517,146,1.07 [0.87-1.32],0.5144199773711369
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24418,47,0.83 [0.56-1.22],0.3412299735956472
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,24403,32,1.21 [0.77-1.89],0.4038046508070028
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24281,1475,1.06 [0.99-1.14],0.0703871059357676
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,22070,1435,1.06 [0.99-1.14],0.0912153728090032
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20999,39,1.05 [0.70-1.58],0.8188199240825234
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23186,53,0.85 [0.59-1.22],0.368780182626501
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21129,169,1.32 [1.09-1.61],0.004345593229489
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21015,55,1.05 [0.74-1.49],0.778664017456905
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23104,2144,1.18 [1.12-1.24],3.667999746729589e-09
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21071,111,1.10 [0.86-1.40],0.4512169755906289
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,21313,353,1.13 [0.99-1.30],0.0732204352668491
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24560,233,1.32 [1.12-1.55],0.0009480632274557
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24421,94,1.55 [1.21-2.00],0.000648217860944
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21053,93,1.04 [0.80-1.36],0.7686128453565847
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20995,35,1.14 [0.74-1.76],0.5420267443266122
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24271,1138,1.10 [1.02-1.19],0.0102995863955394
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21076,116,1.07 [0.85-1.36],0.5652783216222597
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21098,138,0.93 [0.75-1.16],0.5241766953012377
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21309,349,1.13 [0.99-1.30],0.0704162538513187
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21017,57,1.09 [0.78-1.52],0.6150697902210361
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24415,88,1.53 [1.18-1.99],0.0014089964049839
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,21233,273,1.11 [0.95-1.30],0.1765691624333165
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,21236,276,1.15 [0.98-1.34],0.0819063461948192
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,22486,53,1.08 [0.76-1.54],0.6543956463517968
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24028,3068,1.15 [1.10-1.21],1.062508851216296e-09
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23160,27,0.81 [0.48-1.36],0.4199142665838606
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23186,53,1.04 [0.73-1.48],0.8338879748929093
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24486,1728,1.01 [0.95-1.07],0.7730877600862258
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24489,1725,1.01 [0.95-1.07],0.8036858124075724
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23165,32,1.46 [0.95-2.26],0.0859267033496738
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24360,1105,1.10 [1.01-1.18],0.0203044386387164
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21766,806,1.12 [1.02-1.22],0.0143196902878787
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24640,112,0.90 [0.71-1.15],0.3975945599311004
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,24402,31,0.95 [0.60-1.51],0.8352780771689693
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23336,81,1.05 [0.79-1.40],0.7431969646048378
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23355,100,1.06 [0.82-1.37],0.6498349951716011
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21071,111,1.54 [1.22-1.95],0.000318611370446
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,23035,109,1.12 [0.88-1.42],0.3665213824462389
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1537,60,0.72 [0.52-1.01],0.0554201778469986
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1634,169,0.94 [0.78-1.14],0.5564659888775056
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22963,37,1.07 [0.72-1.57],0.7469492443929844
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1509,32,0.99 [0.64-1.54],0.979394626752892
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24281,1355,1.11 [1.04-1.19],0.0019965326569514
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,24433,62,0.90 [0.65-1.26],0.5495769670510999
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22682,249,1.00 [0.85-1.18],0.9812003464901862
VASP,Vasodilator-stimulated phosphoprotein,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21326,366,1.19 [1.04-1.36],0.0098556213100172
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24567,152,0.87 [0.70-1.07],0.1854490337947187
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23978,49,0.99 [0.69-1.43],0.9775639857807296
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Angina pectoris,23515,715,1.00 [0.91-1.10],0.987493142192052
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Aortic aneurysm,24023,94,1.07 [0.83-1.39],0.6001259652976462
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23957,28,1.50 [0.96-2.35],0.0774883877485963
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",24025,96,1.04 [0.80-1.34],0.7801356645680487
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17504,823,1.00 [0.91-1.09],0.9943867395035576
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,AV-block,22424,164,1.00 [0.82-1.22],0.9843929188882876
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24620,233,0.83 [0.70-0.99],0.0399197161027498
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cardiac arrest,16777,96,1.02 [0.78-1.32],0.9082131181711194
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22379,119,0.89 [0.70-1.13],0.3285094275321719
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",22336,76,0.88 [0.65-1.19],0.4235231754918414
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24651,15,0.53 [0.26-1.10],0.0887434342177478
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Conduction disorders,22741,481,0.97 [0.86-1.09],0.6234709595801451
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23995,1204,1.13 [1.05-1.21],0.0013409896905753
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22900,5418,1.07 [1.04-1.11],6.359106638053114e-05
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23616,160,0.88 [0.72-1.08],0.2300156714516575
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Endocarditis,22301,41,0.61 [0.40-0.94],0.0255927673202442
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24539,463,1.05 [0.93-1.18],0.4524407233772364
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypertension,23409,4411,1.08 [1.04-1.12],0.0001499558089663
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23418,4420,1.08 [1.04-1.12],0.0001698794499659
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24490,49,0.70 [0.48-1.02],0.0668068603620777
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19080,82,0.81 [0.61-1.09],0.1669869526869711
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19040,42,0.85 [0.57-1.28],0.442833026578971
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Hypotension,24560,615,1.01 [0.91-1.12],0.8738904735689774
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,24170,59,1.06 [0.76-1.48],0.7165345992528552
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24146,1346,1.10 [1.02-1.17],0.0092565329334023
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24447,282,1.08 [0.93-1.26],0.311057588589991
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Left bundle-branch block,22447,187,1.05 [0.87-1.26],0.6436985369636241
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24423,542,1.11 [1.00-1.24],0.0557151889423421
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",23241,441,1.15 [1.02-1.30],0.0191251884207715
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24600,106,1.01 [0.79-1.29],0.939760944844257
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24636,187,1.20 [1.00-1.44],0.0521030553403184
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Oesophageal varices,23487,31,0.56 [0.34-0.92],0.0209165630412251
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other aneurysm,23971,42,0.79 [0.52-1.19],0.2533937723381319
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other arrhythmias,22487,227,1.02 [0.86-1.20],0.8591377335814657
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23989,60,1.25 [0.91-1.72],0.1622416035134898
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,24062,133,0.89 [0.71-1.11],0.2911464488589116
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22377,117,0.95 [0.75-1.21],0.6670412196255207
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other disorders of veins,23520,64,0.88 [0.63-1.22],0.4399494530492442
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,23502,46,1.11 [0.76-1.61],0.5988648452527017
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23944,35,0.87 [0.56-1.35],0.5258280572231633
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,23537,81,0.90 [0.67-1.20],0.464000169987398
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22791,531,0.99 [0.89-1.11],0.8803528168176429
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23987,42,0.73 [0.49-1.10],0.1317570265360991
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24241,312,1.10 [0.95-1.27],0.1908309796842288
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24245,139,0.93 [0.75-1.16],0.5302048741249974
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",24120,211,0.98 [0.82-1.16],0.7842721342546943
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16895,214,1.00 [0.83-1.19],0.9647985114539274
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Peripheral artery disease,24091,184,1.10 [0.91-1.32],0.3293122831119857
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23677,221,1.01 [0.85-1.20],0.94634397184883
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24406,300,1.08 [0.93-1.25],0.3001753224033643
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24612,289,1.02 [0.87-1.18],0.8378138632607661
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22413,153,0.88 [0.71-1.08],0.2181825154177868
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24242,136,0.94 [0.75-1.17],0.5564191780051788
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,24013,104,1.05 [0.82-1.35],0.7134401653174278
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24440,329,1.07 [0.93-1.23],0.3549987969528743
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24417,363,1.03 [0.90-1.18],0.62295654486066
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,24150,52,0.96 [0.67-1.38],0.8419090073032641
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23978,50,0.89 [0.62-1.29],0.5415152762493396
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Transient ischemic attack,24285,120,1.16 [0.92-1.46],0.202819846232505
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,24042,161,1.03 [0.85-1.26],0.7425187237793396
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Varicose veins,23731,275,0.89 [0.76-1.04],0.1540005739731922
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23939,47,1.10 [0.76-1.60],0.6076750114672982
VASP,Vasodilator-stimulated phosphoprotein,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24492,467,1.05 [0.93-1.18],0.4057849508678507
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24503,336,0.95 [0.83-1.09],0.476906317594808
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21949,1268,1.10 [1.02-1.18],0.0122889898730444
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Any mental disorder,23969,3288,1.04 [0.99-1.09],0.0822917221593132
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24447,393,0.99 [0.87-1.13],0.8937595671644216
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22186,1505,1.05 [0.98-1.12],0.1317164294505047
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20759,78,1.05 [0.78-1.40],0.7628616276933474
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Smoking dependency,24158,1368,1.00 [0.93-1.07],0.9841609311746096
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22256,1575,1.00 [0.94-1.07],0.970321949791144
VASP,Vasodilator-stimulated phosphoprotein,Chapter V Mental and behavioural disorders,Vascular dementia,24549,18,0.79 [0.43-1.45],0.4419911008581495
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Alzheimer disease,24650,65,0.89 [0.64-1.23],0.4642836278099345
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Bell's palsy,23152,68,0.91 [0.67-1.25],0.5665347558902342
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23513,429,1.03 [0.91-1.16],0.6810343746938838
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Cerebral cysts,24329,180,1.07 [0.88-1.29],0.5127108674780574
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24571,204,1.02 [0.85-1.22],0.8204488035226318
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,24515,21,0.86 [0.49-1.54],0.6173621410315455
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24639,50,1.15 [0.81-1.65],0.4358645088159091
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",24200,51,0.87 [0.60-1.26],0.4609087818176626
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Epilepsy,23262,234,0.94 [0.79-1.12],0.4888607746817817
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,24213,1185,1.06 [0.98-1.14],0.1242360312858321
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24623,172,1.10 [0.91-1.34],0.3181322604921008
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24195,1484,0.99 [0.92-1.05],0.680246321621298
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Generalized epilepsy,24315,48,1.20 [0.84-1.73],0.3117312137692376
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Hemiplegia,24517,150,1.01 [0.82-1.24],0.9514984524379808
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Hydrocephalus,24193,44,1.50 [1.04-2.16],0.03105879508212
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24628,62,1.31 [0.96-1.80],0.08891549836501
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,23154,70,0.95 [0.70-1.31],0.7716772302467192
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,23157,73,1.11 [0.83-1.49],0.4848601692264693
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Memory loss,24516,68,1.00 [0.73-1.36],0.9831792574153376
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Migraine,23397,369,1.13 [0.99-1.29],0.0819278947337556
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24573,334,1.12 [0.98-1.29],0.1040400503670511
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Motor neuron disease,17913,92,1.11 [0.85-1.44],0.4508598709164099
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24455,136,0.91 [0.72-1.14],0.4108011905833432
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",24105,1021,1.03 [0.95-1.12],0.4411206477144017
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Neurological diseases,23347,2724,1.04 [0.99-1.09],0.1453424179421097
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,24563,69,1.21 [0.89-1.63],0.2190730204888986
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23437,353,1.02 [0.89-1.17],0.7643942259869061
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24586,207,0.93 [0.78-1.11],0.4168897449020664
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20553,288,0.98 [0.84-1.14],0.7777951744625072
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,24203,54,0.90 [0.63-1.29],0.5709842298024356
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other disorders of nervous system,24257,108,0.81 [0.63-1.04],0.1036867997251516
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24524,73,1.08 [0.80-1.46],0.6123083469434718
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other facial nerve disorders,23170,86,0.91 [0.69-1.20],0.4889798734145032
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other headache syndromes,23083,55,1.15 [0.82-1.62],0.4209236368065054
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other neurological diseases,24543,394,1.03 [0.90-1.17],0.6777490585898696
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Other sleep disorders,23550,522,1.06 [0.95-1.19],0.2774619955812125
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Parkinson's disease,24638,79,1.12 [0.84-1.49],0.4530225226444966
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,24205,56,1.11 [0.78-1.56],0.5597483510820189
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Restless leg syndrome,24649,34,1.12 [0.72-1.73],0.6183568575064675
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Sleep apnoea,24427,453,1.09 [0.97-1.22],0.1616167924054148
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24411,32,1.40 [0.91-2.16],0.128654956690637
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24634,116,1.07 [0.85-1.36],0.5543196683869687
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,23112,28,0.87 [0.53-1.43],0.584866167163415
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24650,66,0.92 [0.67-1.27],0.6088742261658842
VASP,Vasodilator-stimulated phosphoprotein,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),24537,17,0.77 [0.41-1.46],0.4280159421035278
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,24217,35,0.90 [0.58-1.41],0.65057666140075
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,24328,189,1.13 [0.94-1.36],0.1984414052612094
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24573,173,0.94 [0.77-1.14],0.5114094725248426
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23979,34,0.79 [0.50-1.25],0.3242960332985058
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,24013,68,1.16 [0.85-1.58],0.3391460591639577
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24566,28,1.14 [0.71-1.84],0.5911955047375094
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,24479,56,1.38 [0.99-1.91],0.0577690385864597
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1512,35,1.08 [0.71-1.63],0.7225551741441172
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1788,72,0.73 [0.54-0.98],0.0379347521325713
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,24255,73,1.03 [0.76-1.39],0.8358354857613433
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24543,555,1.04 [0.93-1.16],0.494529071042297
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24370,425,0.95 [0.84-1.08],0.4158601239711217
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,24069,124,0.90 [0.71-1.15],0.4060355833777784
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24567,428,1.10 [0.97-1.25],0.1225031245725337
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24643,50,0.73 [0.50-1.07],0.1024427473719774
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24498,359,1.13 [0.98-1.29],0.0859641480541391
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24613,190,1.07 [0.89-1.29],0.4566769248827679
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24594,120,0.84 [0.66-1.07],0.1649274299686355
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23960,15,0.94 [0.48-1.84],0.8613181943891317
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23972,27,1.12 [0.69-1.83],0.6440055830004954
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23975,30,0.81 [0.49-1.32],0.3923681728540819
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24608,343,1.07 [0.93-1.22],0.3576657479692923
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,24348,83,0.94 [0.71-1.25],0.6795578865686499
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,24161,22,1.27 [0.74-2.17],0.3785829887982654
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24485,62,1.14 [0.83-1.57],0.4283659673519037
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24553,130,1.08 [0.86-1.35],0.5223103468048163
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,24286,147,1.08 [0.88-1.34],0.454111180825505
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24544,70,0.92 [0.68-1.26],0.6219748757940555
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24491,226,1.11 [0.94-1.31],0.2201753957980166
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,24282,100,1.18 [0.92-1.52],0.1956817034180465
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,24020,958,1.06 [0.98-1.15],0.1601488471150489
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24531,108,1.15 [0.90-1.47],0.247860505047534
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24629,102,1.08 [0.84-1.39],0.5713647773360545
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,24179,234,0.99 [0.84-1.17],0.9208644843675856
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24458,35,0.98 [0.63-1.52],0.9391848024829988
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24628,35,0.75 [0.48-1.18],0.2114950651675815
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23980,35,0.93 [0.60-1.46],0.7646764857052526
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,24049,104,1.02 [0.79-1.31],0.8981376564066945
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,24046,58,0.84 [0.59-1.18],0.3084483702909539
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,24189,50,1.00 [0.69-1.44],0.9933953878333726
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",24036,48,0.98 [0.68-1.43],0.9309922871389488
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,24312,47,1.26 [0.87-1.82],0.222785006308547
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",24347,82,0.86 [0.64-1.15],0.3127884523946142
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,24019,74,1.09 [0.81-1.47],0.5671667640114886
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,24096,108,1.28 [1.01-1.63],0.0436770042416726
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,24019,31,0.89 [0.55-1.42],0.6208330513438793
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23796,734,1.07 [0.97-1.17],0.1745551940121992
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23989,44,0.81 [0.54-1.22],0.3125102061883927
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24455,273,1.06 [0.91-1.24],0.4625844828789927
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,24214,32,0.79 [0.49-1.26],0.3163227817695803
VASP,Vasodilator-stimulated phosphoprotein,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),24295,113,1.07 [0.85-1.36],0.5610424387158226
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24466,56,0.73 [0.51-1.04],0.0836786673707648
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24609,84,0.99 [0.74-1.31],0.9201814238055834
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24539,128,0.96 [0.76-1.21],0.7210969939008298
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,24461,51,1.04 [0.73-1.50],0.8131547962994229
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,24461,51,1.04 [0.73-1.49],0.8203433530652101
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24565,484,1.04 [0.93-1.17],0.4738077875297807
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,24380,299,1.08 [0.93-1.25],0.2982790173556944
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,24170,89,1.02 [0.78-1.34],0.8727527380468336
VASP,Vasodilator-stimulated phosphoprotein,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,24152,71,1.23 [0.92-1.66],0.1677825351828642
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute pharyngitis,24385,69,0.76 [0.55-1.06],0.1027910035926801
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24530,214,0.91 [0.76-1.08],0.2766534147893258
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,24374,58,0.82 [0.58-1.16],0.2643432525901729
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,All influenza,23478,71,1.09 [0.80-1.47],0.5954787096171152
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),23477,70,1.11 [0.82-1.50],0.4939568736038358
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Allergic asthma (mode),18225,119,1.06 [0.84-1.34],0.6373094822173818
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Allergic rhinitis,24524,284,1.09 [0.94-1.27],0.2718905792719889
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19542,1573,1.07 [1.00-1.14],0.0483330343322324
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19648,1542,1.07 [1.00-1.15],0.0364095630025576
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24395,88,1.35 [1.03-1.75],0.0282284202077259
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23458,51,1.48 [1.04-2.09],0.0274034101415798
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Bronchiectasis,21919,160,1.23 [1.01-1.50],0.0442507781483745
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21793,34,0.97 [0.62-1.52],0.9076291310552328
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23863,2104,1.07 [1.01-1.13],0.0136794992629733
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23316,60,1.17 [0.85-1.63],0.3401849549033863
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Chronic sinusitis,23404,148,1.34 [1.09-1.64],0.0051131012858773
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24558,646,1.04 [0.94-1.15],0.4933163329671982
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Deviated nasal septum,23377,121,1.08 [0.85-1.36],0.5368787879147806
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22908,3805,1.08 [1.04-1.13],0.0003228811913532
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23603,347,1.06 [0.92-1.21],0.4235408658875027
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Early onset COPD,24377,465,1.04 [0.92-1.17],0.5105418598476008
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Emphysema,21927,168,1.21 [1.00-1.47],0.0531847405340601
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23495,102,0.98 [0.76-1.26],0.8593086900238096
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24483,1076,1.07 [0.99-1.15],0.1117110027298642
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Interstitial lung disease,23517,124,1.04 [0.83-1.31],0.7193788417794906
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Later onset COPD,23326,181,1.04 [0.86-1.26],0.7112528783541459
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24643,138,0.92 [0.73-1.14],0.4371521786129125
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Nasal polyp,23363,107,1.12 [0.88-1.44],0.3480537408385924
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24451,572,1.14 [1.03-1.27],0.0140159603155208
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other diseases of pleura,24484,1126,1.10 [1.02-1.19],0.0111890037347828
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,24064,808,1.12 [1.02-1.23],0.0129295046476292
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other pleural conditions,23391,33,1.08 [0.69-1.69],0.7352599826096153
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24595,182,0.96 [0.80-1.17],0.7127940592160159
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24574,770,1.13 [1.03-1.24],0.0073810735347808
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pleural effusion,23901,543,1.09 [0.98-1.22],0.1038091047834029
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pleural plaque,23407,49,1.06 [0.74-1.53],0.7410666507588891
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24293,886,1.05 [0.97-1.15],0.2462275939603912
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24625,120,0.95 [0.75-1.21],0.6832287363046237
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pneumothorax,23416,58,1.34 [0.96-1.86],0.0816386673555111
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pollen allergy,24624,246,1.07 [0.91-1.26],0.4416836122350513
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Pulmonary oedema,24449,36,0.73 [0.47-1.14],0.1683650422579705
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Respiratory insufficiency,18139,33,1.18 [0.76-1.83],0.4692699534101626
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24431,552,1.13 [1.01-1.26],0.0281197132092087
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23540,284,1.09 [0.94-1.27],0.2419267125250653
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Viral pneumonia,23575,168,1.04 [0.85-1.27],0.6880587885640301
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",24409,144,0.98 [0.79-1.21],0.8577576725415239
VASP,Vasodilator-stimulated phosphoprotein,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14193,88,1.00 [0.75-1.32],0.9728930608646148
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18855,60,1.00 [0.72-1.39],0.9872690748189468
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute appendicitis,24469,137,0.90 [0.72-1.13],0.3668133202030649
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute gastritis,19690,62,0.83 [0.59-1.17],0.2878801239439443
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute pancreatitis,23203,155,1.03 [0.84-1.27],0.7488480244162317
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Acute peritonitis,24238,61,1.14 [0.83-1.58],0.4190138920904336
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23953,79,0.89 [0.66-1.19],0.419288772006723
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Barrett oesophagus,19948,320,0.96 [0.83-1.11],0.5517783940686376
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",23100,52,1.01 [0.71-1.44],0.9609050629760788
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24286,52,1.01 [0.71-1.44],0.9533817133995288
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Cholecystitis,23206,158,0.98 [0.80-1.20],0.841898567348703
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Cholelithiasis,23888,840,1.05 [0.96-1.15],0.2427638298196974
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Chronic gastritis,19851,223,1.10 [0.92-1.30],0.2964050798934206
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Chronic pancreatitis,23088,40,0.92 [0.61-1.38],0.6703367799758377
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24518,77,0.72 [0.53-0.97],0.0317487706921474
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Coeliac disease,23371,101,1.04 [0.80-1.34],0.7747275577472633
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Collagenous colitis,23250,50,1.32 [0.93-1.88],0.1209068626299315
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24475,187,0.96 [0.79-1.16],0.6491147064830382
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Constipation,24457,1039,1.02 [0.95-1.11],0.552304132555072
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Crohn disease,23282,82,1.13 [0.86-1.50],0.3846937853808073
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24335,54,1.21 [0.86-1.71],0.2691345827058546
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Crohn's disease NAS,23277,77,1.17 [0.87-1.56],0.2989138261761835
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Dental caries,23905,232,1.10 [0.93-1.30],0.2450847664015675
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22775,1612,1.01 [0.95-1.08],0.6843310530975164
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of appendix,24508,176,0.98 [0.80-1.19],0.8289289714571493
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of liver,24545,671,1.06 [0.96-1.17],0.2340153251268207
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23087,3459,1.02 [0.97-1.06],0.4826191416159993
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",24215,542,1.10 [0.98-1.23],0.0936803347684279
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24572,395,1.19 [1.04-1.35],0.0085514484852563
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23789,116,1.20 [0.95-1.52],0.1256159213888226
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23650,62,1.23 [0.89-1.69],0.2057384072711312
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24395,1125,1.07 [0.99-1.15],0.0844655606981071
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diseases of tongue,23654,110,1.04 [0.81-1.33],0.7457533926426427
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",24189,1141,1.02 [0.94-1.10],0.682792743653355
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20972,2177,1.06 [1.00-1.12],0.0408834404530804
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Duodenal ulcer,19760,132,0.99 [0.79-1.24],0.9598730861056802
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24584,101,0.99 [0.76-1.27],0.9083227481942152
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24532,74,1.46 [1.09-1.94],0.0106145814385868
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23969,95,0.87 [0.67-1.13],0.3040675595985621
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18955,160,0.92 [0.75-1.12],0.3978608266317531
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Functional dyspepsia,20088,460,0.97 [0.86-1.10],0.6399027466149099
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastric ulcer,19885,257,0.95 [0.81-1.11],0.5175131209111383
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21637,2009,1.06 [1.00-1.12],0.0490259691071772
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20001,373,0.96 [0.84-1.10],0.573653918037134
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20066,7160,1.03 [1.00-1.07],0.0326181730520012
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,GI-bleeding,24171,901,1.04 [0.95-1.13],0.3991161707992635
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23733,60,1.19 [0.86-1.66],0.2961893876494338
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19607,1140,1.10 [1.02-1.18],0.0182262142556069
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23922,48,1.10 [0.76-1.59],0.6039651141571165
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Hernia,23597,2434,1.01 [0.96-1.06],0.7196174699124875
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Impacted teeth,24541,69,1.61 [1.20-2.16],0.0014564794757243
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Impaction of intestines,18827,32,1.46 [0.94-2.26],0.0906426571192312
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Inguinal hernia,21775,612,1.01 [0.91-1.12],0.8490143896900663
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",21236,73,1.00 [0.74-1.36],0.9932879020442988
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18861,66,0.90 [0.65-1.25],0.5264752795039478
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23392,122,1.18 [0.93-1.48],0.1702756011979158
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19314,519,1.07 [0.95-1.20],0.2607219497173835
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24627,346,1.14 [1.00-1.31],0.0509009524523383
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23821,621,1.10 [0.99-1.21],0.080526505712268
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23981,781,1.15 [1.05-1.26],0.0027790704104746
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19755,127,1.31 [1.05-1.63],0.0175768930335662
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oesophagitis,20070,442,1.15 [1.02-1.30],0.0238433353014782
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24610,122,1.05 [0.83-1.33],0.6721306334921617
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,21208,45,1.13 [0.78-1.65],0.520636388523219
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19957,1162,1.02 [0.95-1.10],0.6032736891759536
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23227,179,0.99 [0.81-1.20],0.889177675870723
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,23193,145,0.90 [0.72-1.12],0.3384757127362651
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of intestine,20154,1359,1.00 [0.94-1.08],0.8974737131613311
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of intestines,23164,4369,1.02 [0.99-1.07],0.219985882080863
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23653,177,1.03 [0.84-1.25],0.7934715655898208
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of liver,24411,537,1.04 [0.93-1.16],0.4796047492649978
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20115,487,0.97 [0.87-1.10],0.6674155284590868
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of pancreas,23124,76,0.96 [0.71-1.29],0.7809754633452952
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24524,347,1.20 [1.05-1.38],0.0077155898860491
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20313,685,0.95 [0.86-1.05],0.3126492333168875
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,24183,913,1.04 [0.96-1.13],0.3588826626249952
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23825,152,1.08 [0.87-1.33],0.4872572194404602
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19879,1084,1.03 [0.95-1.11],0.4726480252145749
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21212,1584,0.96 [0.90-1.03],0.2711305863452319
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23950,76,0.86 [0.63-1.15],0.3066444973308379
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23880,680,1.09 [0.99-1.21],0.0713518656046552
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19009,214,1.19 [1.00-1.41],0.0520991172265777
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24517,87,1.31 [1.00-1.72],0.0493920207852549
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19111,316,1.09 [0.94-1.26],0.2449391860382084
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23396,126,1.22 [0.97-1.52],0.0888607146118715
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24640,56,1.16 [0.82-1.63],0.3977810326966088
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23686,117,1.10 [0.87-1.40],0.4097420170448833
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Toxic colitis,23223,23,0.78 [0.45-1.36],0.3879005776092986
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19799,171,1.04 [0.86-1.27],0.675064047388666
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ulcerative colitis,23334,134,1.49 [1.21-1.85],0.0002086270163509
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23317,117,1.45 [1.16-1.82],0.0013615863029676
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Umbilical hernia,21405,242,0.88 [0.75-1.04],0.1383537960972505
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18893,98,1.20 [0.93-1.56],0.1560116042334723
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Ventral hernia,21375,212,1.17 [0.99-1.40],0.0715146556524609
VASP,Vasodilator-stimulated phosphoprotein,Chapter XI Diseases of the digestive system,Volvulus,18853,58,1.03 [0.73-1.44],0.874640599748299
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24609,140,1.09 [0.88-1.36],0.4135398627495733
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,24412,75,0.83 [0.61-1.12],0.2287094201183576
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23314,133,0.97 [0.77-1.22],0.7810389206874595
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,24070,499,1.02 [0.91-1.15],0.6838699410138831
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23756,185,1.06 [0.88-1.27],0.5578580715505679
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,23334,153,1.05 [0.85-1.29],0.6493053257941453
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,24417,209,1.14 [0.95-1.35],0.1559908078713731
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24562,354,1.07 [0.94-1.23],0.3207931903355674
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,24249,41,1.20 [0.81-1.78],0.3706362440979114
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23325,2308,1.04 [0.99-1.10],0.1577294787885793
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24232,382,0.93 [0.82-1.07],0.3151180681406439
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,24117,267,0.95 [0.81-1.12],0.5500826310392483
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24287,716,1.04 [0.95-1.14],0.4106657787439164
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24638,43,1.55 [1.07-2.25],0.0217563294995601
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,23235,54,0.94 [0.66-1.35],0.7390496896714058
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23888,38,1.24 [0.83-1.86],0.3021336208141401
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,24411,203,1.14 [0.95-1.36],0.1487707666956436
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23451,270,1.11 [0.95-1.30],0.1740452500795942
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,23215,34,1.21 [0.78-1.87],0.3900650234038578
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24574,66,0.98 [0.72-1.35],0.9198490748451668
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23691,120,1.32 [1.05-1.65],0.0167759103019835
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24472,135,0.79 [0.63-1.00],0.046073216149092
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,24233,25,0.71 [0.41-1.21],0.2028016261043659
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,23229,48,0.92 [0.63-1.35],0.6720829327891145
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,24186,1005,1.04 [0.96-1.13],0.2937619342763635
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23481,300,1.16 [1.00-1.34],0.0512833825585578
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,23219,38,1.33 [0.89-2.00],0.1653934475119995
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24575,238,0.93 [0.79-1.10],0.4036892850491957
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24263,55,0.68 [0.47-0.98],0.0401581176681787
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24531,194,0.84 [0.70-1.02],0.0749231420727138
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24623,154,1.09 [0.88-1.34],0.4274043945503524
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23292,111,1.08 [0.84-1.38],0.5573649204848478
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23356,175,1.03 [0.84-1.25],0.7964885203104346
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24617,148,1.06 [0.86-1.31],0.5706232203682517
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23299,118,1.01 [0.80-1.27],0.9591713537171564
VASP,Vasodilator-stimulated phosphoprotein,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24618,110,0.99 [0.77-1.26],0.9268034526580304
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21609,120,1.16 [0.92-1.46],0.2240862432018646
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22987,4181,1.00 [0.96-1.04],0.9898603776247524
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21771,2965,1.00 [0.95-1.05],0.9746262136121138
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21575,86,0.97 [0.74-1.29],0.8512528101938114
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,22084,142,1.02 [0.82-1.27],0.8429485268000283
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,22087,145,1.26 [1.02-1.55],0.0301249119936674
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,24439,106,0.89 [0.69-1.15],0.3608535421862787
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21985,43,0.98 [0.66-1.46],0.9346437845719991
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19491,685,1.00 [0.90-1.10],0.9262404937527368
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24592,116,0.91 [0.71-1.16],0.4344047849259623
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,22202,260,0.99 [0.85-1.17],0.9385716352067408
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21535,5598,1.01 [0.98-1.05],0.5711634673856114
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23387,100,1.03 [0.80-1.33],0.8209163681488716
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21599,110,0.86 [0.67-1.10],0.2357106769506687
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,22045,556,1.05 [0.94-1.17],0.3687397889867631
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23838,1896,1.04 [0.98-1.10],0.2462319402488493
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21696,207,1.22 [1.02-1.46],0.02592036301615
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21755,266,1.24 [1.06-1.45],0.0073454671650515
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21625,136,1.15 [0.92-1.44],0.2080219171337388
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,24162,33,1.15 [0.74-1.79],0.5484473784672983
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19978,1172,1.03 [0.96-1.11],0.4376362880488316
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19152,346,1.05 [0.91-1.20],0.5137715228543283
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24600,336,1.05 [0.92-1.21],0.4521443389274291
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18875,69,1.02 [0.75-1.40],0.8877177376317773
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19120,314,0.91 [0.78-1.05],0.1964966733850547
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21788,299,1.01 [0.87-1.17],0.884693105413491
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19487,681,0.99 [0.90-1.09],0.8632413049900247
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21968,26,1.00 [0.60-1.67],0.9970730580625132
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22446,504,1.09 [0.98-1.23],0.1216438536000159
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,22200,258,0.97 [0.82-1.14],0.6924436528117974
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19438,632,0.97 [0.88-1.08],0.6088245175578276
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21559,70,1.23 [0.91-1.67],0.1699476002486045
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21545,56,0.93 [0.66-1.33],0.7009069914963622
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,23342,55,1.13 [0.81-1.58],0.4802445774889178
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24350,1063,1.02 [0.94-1.10],0.6528669241017779
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23891,604,1.04 [0.93-1.15],0.5067718546846713
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24542,314,1.14 [0.99-1.32],0.0694421904277917
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,20414,1608,1.00 [0.94-1.07],0.9334658509020604
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18874,68,0.88 [0.64-1.21],0.4322848039410081
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21560,71,1.20 [0.89-1.63],0.2286399499601118
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18832,26,0.87 [0.52-1.46],0.6103682347700294
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18909,103,1.01 [0.78-1.30],0.942784592631824
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23501,214,0.96 [0.80-1.15],0.653203995278264
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23512,225,0.97 [0.82-1.16],0.7699655296147545
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24614,77,0.89 [0.66-1.21],0.4638674617755165
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23356,1414,1.05 [0.98-1.12],0.1627233269703274
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21599,110,0.83 [0.65-1.07],0.1580088498649131
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18918,112,0.76 [0.59-0.98],0.0329565558077912
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22513,571,0.98 [0.88-1.09],0.7209440749029175
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20647,1841,1.01 [0.95-1.07],0.7275463188566491
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,24182,53,1.19 [0.84-1.68],0.3314489084981946
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24625,72,0.92 [0.67-1.25],0.575127953077329
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21560,71,1.32 [0.98-1.78],0.0681367684184291
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",22480,991,1.03 [0.95-1.12],0.5115525562758696
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21552,63,0.99 [0.72-1.38],0.9759862739186664
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19826,1020,1.06 [0.98-1.15],0.1558695616448941
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23384,97,1.05 [0.81-1.37],0.7022139310444385
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21548,59,1.11 [0.79-1.55],0.5519319105005134
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,22046,104,0.94 [0.73-1.21],0.639184642768406
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21844,355,0.95 [0.82-1.09],0.4271772318842664
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24320,191,1.17 [0.98-1.41],0.0898398584592538
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22372,430,1.03 [0.91-1.16],0.691116390309389
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24551,299,1.16 [1.00-1.34],0.0480135751336276
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24633,35,1.02 [0.66-1.58],0.9290324928913664
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21678,189,1.02 [0.84-1.23],0.8487522670395261
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19757,556,1.08 [0.97-1.21],0.147839389387539
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21934,445,0.96 [0.85-1.08],0.4748139710225865
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21643,154,1.26 [1.03-1.55],0.0255627133340819
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18841,35,0.67 [0.42-1.06],0.0886612162849312
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20404,1598,1.05 [0.99-1.12],0.1275654921457014
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19212,406,0.94 [0.83-1.07],0.3416230711646282
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,24209,80,1.29 [0.98-1.71],0.0724114705911929
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24582,45,0.89 [0.60-1.32],0.5729824112536696
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",23211,27,1.09 [0.67-1.76],0.731692125733314
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18880,74,0.90 [0.66-1.22],0.5026638873985453
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,22026,84,1.05 [0.80-1.40],0.7169391703350761
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19124,318,1.14 [0.99-1.31],0.0764926496986139
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21732,243,0.92 [0.78-1.09],0.3533238424234147
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,22139,197,1.11 [0.92-1.33],0.2826679511535173
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,22038,96,1.06 [0.81-1.38],0.6825053560418228
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20820,44,1.24 [0.85-1.82],0.2651030343657977
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24636,38,0.94 [0.61-1.43],0.760642729479421
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,22030,541,1.00 [0.89-1.11],0.9628886937492136
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],24205,76,0.97 [0.72-1.30],0.8248551308180976
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23684,2195,1.03 [0.97-1.08],0.3603757301446543
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21592,103,1.00 [0.78-1.29],0.9892777874647742
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,22269,327,1.03 [0.89-1.19],0.6818577231370759
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,23373,170,1.06 [0.87-1.29],0.5571676451154275
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,22078,136,0.94 [0.75-1.18],0.5976541332690731
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22911,969,1.01 [0.92-1.09],0.9059932834721934
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22579,637,0.98 [0.89-1.09],0.7379110684822101
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21530,41,1.23 [0.83-1.83],0.3085361999631678
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24273,144,1.08 [0.87-1.34],0.486836425323522
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21630,141,1.06 [0.85-1.31],0.6295550201542293
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21543,54,0.82 [0.57-1.18],0.2767858993538312
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18840,34,0.92 [0.59-1.44],0.7184679715930129
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24182,763,1.08 [0.98-1.18],0.1080846632350842
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9994,65,1.02 [0.74-1.42],0.8985692891583564
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13308,72,0.85 [0.62-1.17],0.3308008969763287
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24383,279,1.07 [0.92-1.25],0.3847463886582108
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,24160,56,0.76 [0.53-1.08],0.1272465639545469
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23991,572,1.04 [0.93-1.15],0.5121064593923319
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24487,20,0.39 [0.20-0.74],0.0038890616264055
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24494,167,0.97 [0.80-1.19],0.7844492078782481
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Cystitis,22643,141,1.10 [0.89-1.36],0.39401470051747
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Dialysis,23463,44,1.23 [0.85-1.79],0.267698878863254
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10661,1016,1.03 [0.95-1.11],0.5246079400080012
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13414,178,0.97 [0.80-1.18],0.7667305175342144
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Endometriosis,10046,117,0.98 [0.77-1.26],0.8796152259199449
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10270,341,0.83 [0.71-0.96],0.0111304590486826
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10314,385,1.05 [0.92-1.20],0.4668721651074958
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20776,3802,1.03 [0.99-1.07],0.1934804100519971
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24526,59,1.03 [0.74-1.44],0.8436980049019732
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Hydrocele,9717,72,1.13 [0.84-1.52],0.4100608498278482
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,23340,200,1.13 [0.94-1.35],0.1820191508879981
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10326,681,1.04 [0.94-1.14],0.481424211032711
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13293,210,0.94 [0.78-1.13],0.5175181923543972
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9737,92,0.86 [0.65-1.13],0.2693622077129849
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Irregular menses,13301,109,0.67 [0.52-0.88],0.0034361692851849
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10195,266,0.95 [0.81-1.13],0.5816194737319327
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22561,59,1.03 [0.74-1.44],0.8490207225832491
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11190,1261,0.99 [0.92-1.06],0.7078946240934931
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9692,47,0.95 [0.65-1.38],0.7885721615628876
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10017,88,1.14 [0.86-1.51],0.3506436062078447
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24640,37,1.27 [0.84-1.91],0.2622368018744656
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24645,43,0.92 [0.62-1.37],0.6759320112153769
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23871,1369,1.08 [1.01-1.16],0.0271198597669267
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22936,434,1.05 [0.93-1.19],0.4128264120805999
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13292,56,1.07 [0.76-1.52],0.6942432111244734
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24603,276,1.09 [0.94-1.27],0.265571222400264
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9785,140,0.90 [0.73-1.13],0.365858146666329
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9752,107,0.93 [0.72-1.19],0.5442878125288619
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9712,67,1.01 [0.74-1.38],0.9522443178889408
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24617,50,1.15 [0.80-1.65],0.4518574693429006
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23506,1004,1.07 [0.99-1.17],0.0807597231038748
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13190,107,1.10 [0.86-1.42],0.4464759038995457
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,10002,73,1.27 [0.95-1.72],0.1113496340315135
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10139,210,1.01 [0.85-1.21],0.8866515576230067
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9983,54,1.38 [0.97-1.95],0.0698928042845234
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,10025,96,1.11 [0.85-1.45],0.4398579703427908
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23372,232,1.13 [0.96-1.34],0.1460997002596857
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,24422,95,1.23 [0.95-1.59],0.1119363801673589
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10088,159,1.07 [0.87-1.31],0.5485336530791489
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,10000,71,0.96 [0.70-1.32],0.8092885227195286
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10308,379,0.98 [0.85-1.12],0.7397434416487709
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9988,59,1.07 [0.77-1.50],0.6804413119074624
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10266,337,1.05 [0.91-1.21],0.48265327821707
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24509,42,1.15 [0.78-1.69],0.4900947677640281
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9745,100,1.37 [1.08-1.75],0.0103325612085836
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24485,1345,1.07 [1.00-1.15],0.0435645724976602
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23266,126,1.11 [0.88-1.40],0.3665559034118942
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23478,59,0.76 [0.54-1.07],0.119917952709492
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24166,62,1.02 [0.74-1.41],0.9028997823029956
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22656,154,1.18 [0.97-1.45],0.1042882874935546
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24441,337,1.01 [0.88-1.16],0.9062032915945152
VASP,Vasodilator-stimulated phosphoprotein,Chapter XIV Diseases of the genitourinary system,Uterine polyps,10018,89,1.11 [0.84-1.46],0.4681007168167492
